Global Genomic Medicine Collaborative
- Assets
- $1.2m
- Revenue
- $952.1k
- Investments
- $0.0
- Employees
- 0
- Location
- Durham, NC
- Founding
- 03/2018
- Data as of
- 12/2022
- EIN
- 81-3079744
Organization Overview
Global Genomic Medicine Collaborative is located in Durham, NC. The organization was established in 2018. According to its NTEE Classification (E05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Global Genomic Medicine Collaborative is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Global Genomic Medicine Collaborative generated $952.1k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 30.4% each year . All expenses for the organization totaled $1.1m during the year ending 12/2022. While expenses have increased by 27.7% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE ENTITY IS ORGANIZED AND OPERATED EXCLUSIVELY FOR CHARITABLE AND EDUCATIONAL PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE TO INCLUDE ADVANCING GENOMIC MEDICINE IN CLINICAL CARE THROUGH GLOBAL COLLABORATIONS. PRIMARY ACTIVITIES INCLUDE COLLABORATIVE DATABASE SHARING OF RESEARCH INFORMATION, AND FACILITATING COMMUNICATION BETWEEN MEDICAL PROFESSIONALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MEETING EXPENSES ASSOCIATED WITH BRINGING TOGETHER MEDICAL EXPERTS AROUND THE WORLD TO IN ORDER TO PURSUE THE ENTITY'S EXEMPT AND CHARITABLE PURPOSE OF ADVANCING GENMOIC MEDICAL RESEARCH AND SOLUTIONS.
COLLABORATIVE RESEARCH IN SHARING DATABASE INFORMATION RELATED TO GENOMIC MEDICINE
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Peter Goodhand Director | OfficerTrustee | 5 | $0 |
Vajira Dissanayake Director | OfficerTrustee | 5 | $0 |
George Patrinos Secretary | OfficerTrustee | 5 | $0 |
Alan Shuldiner Director | OfficerTrustee | 5 | $0 |
Catalina Lopez-Correa Director | Trustee | 5 | $0 |
Gabriela M Repetto Director | Trustee | 5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $951,989 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $951,989 |
| Total Program Service Revenue | $0 |
| Investment income | $81 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $952,070 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $215,705 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $200,777 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $336 |
| Information technology | $20,071 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $404 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $675 |
| Total functional expenses | $1,082,162 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,234,362 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,234,362 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $875 |
| Total liabilities | $875 |
| Net assets without donor restrictions | $733,487 |
| Net assets with donor restrictions | $500,000 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,234,362 |
Grants Awarded
Over the last fiscal year, Global Genomic Medicine Collaborative has awarded $172,578 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
CHILDREN'S HOSPITAL OF PHILADELPHIA PURPOSE: DATABASE RESEARCH DEVELOPMENT | $117,500 |
UNIVERSITY OF MARYLAND BALTIMORE PURPOSE: DATABASE RESEARCH DEVELOPMENT | $55,078 |